...
首页> 外文期刊>Therapeutic innovation & regulatory science. >Good Clinical Practice Training: Identifying Key Elements and Strategies for Increasing Training Efficiency
【24h】

Good Clinical Practice Training: Identifying Key Elements and Strategies for Increasing Training Efficiency

机译:良好的临床实践培训:确定提高培训效率的关键要素和策略

获取原文
获取原文并翻译 | 示例
           

摘要

Good Clinical Practice (GCP) is an international standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials. The goal of GCP is to ensure the protection of the rights, integrity, and confidentiality of clinical trial participants and to ensure the credibility and accuracy of data and reported results. In the United States, trial sponsors generally require investigators to complete GCP training prior to participating in each clinical trial to foster GCP and as a method to meet regulatory expectations (ie, sponsor's responsibility to select qualified investigators per 21 CFR 312.50 and 312.53(a) for drugs and biologics and 21 CFR 812.40 and 812.43(a) for medical devices). This training requirement is often extended to investigative site staff, as deemed relevant by the sponsor, institution, or investigator. Those who participate in multiple clinical trials are often required by sponsors to complete repeated GCP training, which is unnecessarily burdensome. The Clinical Trials Transformation Initiative convened a multidisciplinary project team involving partners from academia, industry, other researchers and research staff, and government to develop recommendations for streamlining current GCP training practices. Recommendations drafted by the project team, including the minimum key training elements, frequency, format, and evidence of training completion, were presented to a broad group of experts to foster discussion of the current issues and to seek consensus on proposed solutions.
机译:良好临床规范(GCP)是一项针对临床试验的设计,实施,性能,监测,审核,记录,分析和报告的国际标准。 GCP的目标是确保保护临床试验参与者的权利,完整性和机密性,并确保数据和报告结果的可信度和准确性。在美国,试验赞助者通常要求研究者在参加每项临床试验以促进GCP之前完成GCP培训,并以此作为满足监管要求的方法(即,赞助者有责任根据21 CFR 312.50和312.53(a)选择合格的研究者。药品和生物制剂的价格为21 CFR 812.40和812.43(a)的医疗设备)。发起人,机构或研究者认为相关的培训要求通常会扩展到现场调查人员。申办者经常要求参加多个临床试验的人完成重复的GCP训练,这不必要地麻烦。临床试验转型计划召集了一个多学科的项目团队,该团队由来自学术界,行业,其他研究人员和研究人员以及政府的合作伙伴组成,以提出简化当前GCP培训实践的建议。由项目团队起草的建议,包括最低限度的关键培训要素,频率,形式和培训完成的证据,已提交给广泛的专家组,以促进对当前问题的讨论并在提议的解决方案上寻求共识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号